BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 17909071)

  • 1. Genetic heterogeneity among Fanconi anemia heterozygotes and risk of cancer.
    Berwick M; Satagopan JM; Ben-Porat L; Carlson A; Mah K; Henry R; Diotti R; Milton K; Pujara K; Landers T; Dev Batish S; Morales J; Schindler D; Hanenberg H; Hromas R; Levran O; Auerbach AD
    Cancer Res; 2007 Oct; 67(19):9591-6. PubMed ID: 17909071
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk of cancer in heterozygous relatives of patients with Fanconi anemia.
    McReynolds LJ; Giri N; Leathwood L; Risch MO; Carr AG; Alter BP
    Genet Med; 2022 Jan; 24(1):245-250. PubMed ID: 34906449
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Shared genetic susceptibility to breast cancer, brain tumors, and Fanconi anemia.
    Offit K; Levran O; Mullaney B; Mah K; Nafa K; Batish SD; Diotti R; Schneider H; Deffenbaugh A; Scholl T; Proud VK; Robson M; Norton L; Ellis N; Hanenberg H; Auerbach AD
    J Natl Cancer Inst; 2003 Oct; 95(20):1548-51. PubMed ID: 14559878
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of Fanconi Anemia genes in familial breast cancer predisposition.
    Seal S; Barfoot R; Jayatilake H; Smith P; Renwick A; Bascombe L; McGuffog L; Evans DG; Eccles D; Easton DF; Stratton MR; Rahman N;
    Cancer Res; 2003 Dec; 63(24):8596-9. PubMed ID: 14695169
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cancer incidence in relatives of British Fanconi Anaemia patients.
    Tischkowitz M; Easton DF; Ball J; Hodgson SV; Mathew CG
    BMC Cancer; 2008 Sep; 8():257. PubMed ID: 18786261
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reassessment of cancer predisposition of Fanconi anemia heterozygotes.
    Swift M; Caldwell RJ; Chase C
    J Natl Cancer Inst; 1980 Nov; 65(5):863-7. PubMed ID: 6933255
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Most Fanconi anemia heterozygotes are not at increased cancer risk: A genome-first DiscovEHR cohort population study.
    Deng J; Altintas B; Haley JS; Kim J; Ramos M; Carey DJ; Stewart DR; McReynolds LJ
    Genet Med; 2024 Mar; 26(3):101042. PubMed ID: 38063144
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessing the spectrum of germline variation in Fanconi anemia genes among patients with head and neck carcinoma before age 50.
    Chandrasekharappa SC; Chinn SB; Donovan FX; Chowdhury NI; Kamat A; Adeyemo AA; Thomas JW; Vemulapalli M; Hussey CS; Reid HH; Mullikin JC; Wei Q; Sturgis EM
    Cancer; 2017 Oct; 123(20):3943-3954. PubMed ID: 28678401
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The risk for developing cancer in Israeli ATM, BLM, and FANCC heterozygous mutation carriers.
    Laitman Y; Boker-Keinan L; Berkenstadt M; Liphsitz I; Weissglas-Volkov D; Ries-Levavi L; Sarouk I; Pras E; Friedman E
    Cancer Genet; 2016 Mar; 209(3):70-4. PubMed ID: 26778106
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Finnish Fanconi anemia mutations and hereditary predisposition to breast and prostate cancer.
    Mantere T; Haanpää M; Hanenberg H; Schleutker J; Kallioniemi A; Kähkönen M; Parto K; Avela K; Aittomäki K; von Koskull H; Hartikainen JM; Kosma VM; Laasanen SL; Mannermaa A; Pylkäs K; Winqvist R
    Clin Genet; 2015 Jul; 88(1):68-73. PubMed ID: 24989076
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutational analysis of FANCL, FANCM and the recently identified FANCI suggests that among the 13 known Fanconi Anemia genes, only FANCD1/BRCA2 plays a major role in high-risk breast cancer predisposition.
    García MJ; Fernández V; Osorio A; Barroso A; Fernández F; Urioste M; Benítez J
    Carcinogenesis; 2009 Nov; 30(11):1898-902. PubMed ID: 19737859
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fanconi anaemia genes and susceptibility to cancer.
    Mathew CG
    Oncogene; 2006 Sep; 25(43):5875-84. PubMed ID: 16998502
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FANCC Dutch founder mutation in a Mennonite family from Tamaulipas, México.
    García-de Teresa B; Frias S; Molina B; Villarreal MT; Rodriguez A; Carnevale A; López-Hernández G; Vollbrechtshausen L; Olaya-Vargas A; Torres L
    Mol Genet Genomic Med; 2019 Jun; 7(6):e710. PubMed ID: 31044565
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Breast cancer and Fanconi anemia: what are the connections?
    Zdzienicka MZ; Arwert F
    Trends Mol Med; 2002 Oct; 8(10):458-60. PubMed ID: 12383764
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biallelic mutations in PALB2 cause Fanconi anemia subtype FA-N and predispose to childhood cancer.
    Reid S; Schindler D; Hanenberg H; Barker K; Hanks S; Kalb R; Neveling K; Kelly P; Seal S; Freund M; Wurm M; Batish SD; Lach FP; Yetgin S; Neitzel H; Ariffin H; Tischkowitz M; Mathew CG; Auerbach AD; Rahman N
    Nat Genet; 2007 Feb; 39(2):162-4. PubMed ID: 17200671
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Coinheritance of BRCA1 and BRCA2 mutations with Fanconi anemia and Bloom syndrome mutations in Ashkenazi Jewish population: possible role in risk modification for cancer development.
    Koren-Michowitz M; Friedman E; Gershoni-Baruch R; Brok-Simoni F; Patael Y; Rechavi G; Amariglio N
    Am J Hematol; 2005 Mar; 78(3):203-6. PubMed ID: 15726604
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Individuals with FANCM biallelic mutations do not develop Fanconi anemia, but show risk for breast cancer, chemotherapy toxicity and may display chromosome fragility.
    Catucci I; Osorio A; Arver B; Neidhardt G; Bogliolo M; Zanardi F; Riboni M; Minardi S; Pujol R; Azzollini J; Peissel B; Manoukian S; De Vecchi G; Casola S; Hauke J; Richters L; Rhiem K; Schmutzler RK; Wallander K; Törngren T; Borg Å; Radice P; Surrallés J; Hahnen E; Ehrencrona H; Kvist A; Benitez J; Peterlongo P
    Genet Med; 2018 Apr; 20(4):452-457. PubMed ID: 28837162
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of breast and colorectal cancer in Ashkenazi Jewish carriers of Fanconi anemia and Bloom syndrome.
    Baris HN; Kedar I; Halpern GJ; Shohat T; Magal N; Ludman MD; Shohat M
    Isr Med Assoc J; 2007 Dec; 9(12):847-50. PubMed ID: 18210922
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Fanconi anemia DNA damage repair pathway in the spotlight for germline predisposition to colorectal cancer.
    Esteban-Jurado C; Franch-Expósito S; Muñoz J; Ocaña T; Carballal S; López-Cerón M; Cuatrecasas M; Vila-Casadesús M; Lozano JJ; Serra E; Beltran S; Brea-Fernández A; Ruiz-Ponte C; Castells A; Bujanda L; Garre P; Caldés T; Cubiella J; Balaguer F; Castellví-Bel S
    Eur J Hum Genet; 2016 Oct; 24(10):1501-5. PubMed ID: 27165003
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Two truncating variants in FANCC and breast cancer risk.
    Dörk T; Peterlongo P; Mannermaa A; Bolla MK; Wang Q; Dennis J; Ahearn T; Andrulis IL; Anton-Culver H; Arndt V; Aronson KJ; Augustinsson A; Freeman LEB; Beckmann MW; Beeghly-Fadiel A; Behrens S; Bermisheva M; Blomqvist C; Bogdanova NV; Bojesen SE; Brauch H; Brenner H; Burwinkel B; Canzian F; Chan TL; Chang-Claude J; Chanock SJ; Choi JY; Christiansen H; Clarke CL; Couch FJ; Czene K; Daly MB; Dos-Santos-Silva I; Dwek M; Eccles DM; Ekici AB; Eriksson M; Evans DG; Fasching PA; Figueroa J; Flyger H; Fritschi L; Gabrielson M; Gago-Dominguez M; Gao C; Gapstur SM; García-Closas M; García-Sáenz JA; Gaudet MM; Giles GG; Goldberg MS; Goldgar DE; Guénel P; Haeberle L; Haiman CA; Håkansson N; Hall P; Hamann U; Hartman M; Hauke J; Hein A; Hillemanns P; Hogervorst FBL; Hooning MJ; Hopper JL; Howell T; Huo D; Ito H; Iwasaki M; Jakubowska A; Janni W; John EM; Jung A; Kaaks R; Kang D; Kapoor PM; Khusnutdinova E; Kim SW; Kitahara CM; Koutros S; Kraft P; Kristensen VN; Kwong A; Lambrechts D; Marchand LL; Li J; Lindström S; Linet M; Lo WY; Long J; Lophatananon A; Lubiński J; Manoochehri M; Manoukian S; Margolin S; Martinez E; Matsuo K; Mavroudis D; Meindl A; Menon U; Milne RL; Mohd Taib NA; Muir K; Mulligan AM; Neuhausen SL; Nevanlinna H; Neven P; Newman WG; Offit K; Olopade OI; Olshan AF; Olson JE; Olsson H; Park SK; Park-Simon TW; Peto J; Plaseska-Karanfilska D; Pohl-Rescigno E; Presneau N; Rack B; Radice P; Rashid MU; Rennert G; Rennert HS; Romero A; Ruebner M; Saloustros E; Schmidt MK; Schmutzler RK; Schneider MO; Schoemaker MJ; Scott C; Shen CY; Shu XO; Simard J; Slager S; Smichkoska S; Southey MC; Spinelli JJ; Stone J; Surowy H; Swerdlow AJ; Tamimi RM; Tapper WJ; Teo SH; Terry MB; Toland AE; Tollenaar RAEM; Torres D; Torres-Mejía G; Troester MA; Truong T; Tsugane S; Untch M; Vachon CM; Ouweland AMWVD; Veen EMV; Vijai J; Wendt C; Wolk A; Yu JC; Zheng W; Ziogas A; Ziv E; ; ; Dunning AM; Pharoah PDP; Schindler D; Devilee P; Easton DF
    Sci Rep; 2019 Aug; 9(1):12524. PubMed ID: 31467304
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.